Globalbit is an Israeli custom software development company. This page is a case study about Pfizer (Pharma & HealthTech). Globalbit built I Grow — a mobile game that turned daily growth hormone injections from a nightly battle into a space adventure. Recognized as Pfizer's Most Innovative Project 2015. Key facts: Most Innovative Project @ Pfizer 2015, gamified injection compliance for children with growth hormone deficiency, real-time clinical data for physicians.

We Turned a Needle Into a Space Mission
Most Innovative Project — global recognition
children initiated treatment through play
first-ever injection compliance tracking for doctors
A Mobile Game That Made Children Want Their Injection
Globalbit built I Grow for Pfizer — a mobile app that turned the daily struggle of growth hormone injections into a space adventure. Children play with superheroes, explore planets, and collect rewards. But before the spaceship can launch, the hero needs an injection. The child picks where — and the app makes sure it rotates evenly across the body. Every dose is logged, tracked, and securely sent to the treating physician. For the first time, doctors got real compliance data instead of parent guesses.

Meet the I Grow universe
Superheroes, galaxies, alien encounters, and rewards. The game was designed by child psychologists and game designers working together — because a medical app with cartoon stickers wouldn't cut it. Children needed something they'd genuinely ask to play. Every character, every planet, every reward loop was calibrated to maintain engagement over months of daily treatment.
Daily Injections, Nightly Battles, Zero Data
Growth hormone deficiency affects thousands of children. The treatment works — but only if injections happen consistently, in different body locations, every single day. In practice, compliance was terrible. And nobody had the data to prove it.
- -Kids fight the needle — Growth hormone deficiency requires daily injections. Every evening becomes a battle. Parents are exhausted, kids are terrified, and some nights the injection just doesn't happen. Missed doses mean slower growth and worse outcomes.
- -Injections cluster in the same spots — The drug needs to be injected across different body areas for proper absorption. But children resist — they want the spot that hurts least. Parents give in. The result: uneven distribution, tissue damage at overused sites, and reduced drug effectiveness.
- -Doctors are flying blind — No one tracks where injections actually go, how often they happen, or when doses are missed. At the quarterly checkup, the doctor asks the parents. The parents guess. Treatment decisions get made on incomplete information.
"Parents told us the hardest part wasn't the medical side. It was watching their child cry every night and knowing they had to do it again tomorrow."
What If the Child Actually Wanted the Injection?
A Game That Tracks, Rotates, and Reports
I Grow combines behavioral game design with clinical-grade injection tracking. Every session generates data that helps doctors make better treatment decisions.


From guesswork to growth charts
The physician dashboard shows real data: growth percentile curves, injection compliance timelines, and body-site distribution maps. Doctors can compare treatment plans against actual adherence — and adjust dosing based on evidence, not memory. Every data point flows through encrypted channels that meet pharmaceutical regulatory standards.

Building a healthcare product that patients actually use?
We've designed compliance solutions for Pfizer, J&J, and Teva. Let's talk about yours.
From Research to Pfizer's Innovation Award in 6 Months

Clinical Precision Inside a Children's Game
The tech stack had to satisfy two completely different audiences: a 6-year-old playing a space game and an endocrinologist reviewing clinical compliance data. Both had to trust the system completely.
Why Pfizer Chose Globalbit for a Pediatric Health Product
Pharma companies don't hand patient-facing products to agencies that haven't worked in regulated healthcare before. Here's what gave Pfizer confidence.

The Nightly Battle Became a Nightly Ritual
I Grow proved that gamification isn't a gimmick when it's designed with clinical rigor. Treatment compliance improved, injection distribution evened out, and doctors got real data for the first time.



